Dr. Flaherty presents a case review of an 85-year-old male who presented with unstable angina symptoms, multivessel coronary artery disease (CAD), severe PVD (right leg intermittent claudication), moderate-severe bioprosthetic aortic valve stenosis, and a depressed ejection fraction (35%). IMP-938
Category: Protected PCI
The 2020 Clinical Dossier: Protected PCI with Impella® is a collection of data and clinical evidence supporting the use of Impella in High-Risk Percutaneous procedures.
With Impella support in high-risk PCI, overall incidence of post-procedural AKI is significantly reduced relative to predicted risk
This sheath enables reaccess to the artery for the duration of Impella support with up to an 0.035” guidewire. The additional sheath length may provide improved hemostasis for tissue tracks longer than 6cm.
Dr. Michael P. Flaherty’s TCT 2018 presentation on Renal Effects of Impella support during Protected PCI.
Download the Mt. Sinai Protected PCI Algorithm to guide decision-making for appropriate use of the Impella 2.5 and Impella CP heart pump for Protected PCI.
Download the WVU Heart & Vascular Institute Complete Revascularization of Complex and High Risk Coronary Artery Disease Algorithm.